Isolated Intravascular Prostate Carcinoma Recurrence Confirmed With 18F-Fluciclovine PET/CT and MRI

被引:0
|
作者
Agely, Ali [1 ]
Sharma, Akash [1 ]
Parent, Ephraim E. [1 ]
Nawaz, Anem [2 ]
Jain, Manoj K. [1 ]
机构
[1] Mayo Clin, Dept Radiol, Jacksonville, FL 32224 USA
[2] Orange Pk Med Ctr, Orange Pk, FL USA
关键词
F-18; fluciclovine; PET/CT; recurrent prostate carcinoma;
D O I
10.1097/RLU.0000000000003011
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Late recurrence of prostate cancer after remission with prior radical prostatectomy is uncommon. This is a unique case of biochemical recurrence after being in remission for 12 years. The patient presented with swelling of the right lower extremity with pelvic MRI demonstrating an arterially enhancing filling defect in the right common iliac. An F-18-fluciclovine PET/CT showed corresponding increased intravascular radiotracer activity. Targeted biopsy of the intravascular lesion showed poorly differentiated carcinoma, suggestive of prostate origin. Although MRI evaluation is the mainstay for pelvic evaluation, characterization with F-18-fluciclovine PET/CT imaging adds high whole-body specificity and diagnostic accuracy.
引用
收藏
页码:442 / 443
页数:2
相关论文
共 50 条
  • [31] Papillary Urothelial Carcinoma of Urinary Bladder Identified on 18F-Fluciclovine PET/CT
    Meka, Vamsi Mohan
    Wankhar, Baphiralyne
    Ojili, Vijayanadh
    Batchala, Prem P.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (08) : E438 - E439
  • [32] The Use of 18F-fluciclovine PET/CT in Prostate Cancer Diagnosis and Therapeutic Decision Making
    Dreyfuss, A.
    Ahn, G. S.
    Barsky, A. R.
    Pantel, A. R.
    Vapiwala, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E883 - E883
  • [33] Negative 18F-Piflufolastat PET/CT, But Positive 18F-Fluciclovine PET/CT, in a Patient With Biochemically Recurrent Prostate Cancer
    Ulaner, Gary A.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (10) : 968 - 970
  • [34] Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer
    Teoh, Eugene J.
    Tsakok, Maria T.
    Bradley, Kevin M.
    Hyde, Katherine
    Subesinghe, Manil
    Gleeson, Fergus V.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) : 803 - 804
  • [35] Understanding and Improving 18F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer
    Lowentritt, Benjamin H.
    Kipper, Michael S.
    PROSTATE CANCER, 2020, 2020
  • [36] Review of 18F-Fluciclovine PET for Detection of Recurrent Prostate Cancer
    Gusman, Mariya
    Aminsharifi, Jamie A.
    Peacock, Justin G.
    Anderson, Shane B.
    Clemenshaw, Michael N.
    Banks, Kevin P.
    RADIOGRAPHICS, 2019, 39 (03) : 822 - 841
  • [37] Effect of androgen-deprivation therapy on the results of PET/CT with 18F-fluciclovine in patients with biochemical recurrence of prostate cancer
    Bach-Gansmo, T.
    Korsan, K.
    Bogsrud, T. V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S602 - S602
  • [38] 18F-Fluciclovine PET/CT Use in the Evaluation of Endometrial Cancer
    Lee, Justin
    Liotta, Margaret
    Buehner, Tina
    Potkul, Ronald
    Lovrec, Petra
    Kim, Yo Sup
    Wagner, Robert
    Savir-Baruch, Bital
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [39] Multifocal Meningiomas Mimicking Metastasis on 18F-Fluciclovine PET/CT
    Aldine, Amro Saad
    Balaawi, Khalid
    Saadeddin, Assim
    Shariftabrizi, Ahmad
    Kandemirl, Sedat
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 55 (05) : 261 - 264
  • [40] The positivity rates of 18F-fluciclovine and 18F-choline PET/CT in men with recurrent prostate cancer
    Lovrec, P.
    Golubic, A.
    Huic, D.
    Wagner, R.
    Gabriel, S.
    Solanki, A.
    Gupta, G.
    Savir-Baruch, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S528 - S528